| Literature DB >> 34295599 |
A V Raveendran1,2, Jothydev Kesavadev3, Parameswaran Hari4, Gopika Krishnan3.
Abstract
The spread of COVID-19 (coronavirus disease 2019) across the world has resulted in widespread morbidity and mortality. An explosive increase in the number of cases during the surge phase of the pandemic can result in a management crisis. Therefore, we propose a simple model to manage the surges of the pandemic.Entities:
Keywords: covid-19; home treatment; management; pandemic; sars-cov-2
Year: 2021 PMID: 34295599 PMCID: PMC8293859 DOI: 10.7759/cureus.15794
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Proposed model to manage the surges of the pandemic
Monitoring and treatment options of COVID-19 at different levels
H2 blocker: Histamine-2 receptor blocker; PPI: Proton pump inhibitor; COVID-19: Coronavirus disease 2019.
| Symptoms | Monitoring | Treatment |
| At-home quarantine | ||
| Fever | Temperature | Paracetamol |
| Body ache | Anti-histamines | |
| Headache | Pulse rate | Antibiotics |
| Running nose | Cough syrup | |
| Cough | Respiratory rate | H2 blockers/PPI |
| Throat pain | Steroids | |
| Breathlessness | Blood pressure | Anti-coagulants |
| Abdominal discomfort | ||
| Diarrhea | Oxygen saturation (SpO2) | |
| Any co-morbidities | Blood glucose with glucometer | Optimization of treatment of co-morbidities |
| Full blood count, inflammatory markers, and biochemical panels if healthcare workers visit | ||
| At first line facility/ field hospital | ||
| Breathlessness | All of the above | All of the above |
| Chest X-ray | Inj. Dexamethasone | |
| Routine blood test including inflammatory markers and biochemical panels | Monoclonal antibody- Inj. Tocilizumab | |
| Inj. Heparin | ||
| Oxygen | ||
| Deterioration of comorbid condition | Monitoring of comorbidities | Optimization of treatment of comorbidities |
| At multidisciplinary tertiary level care | ||
| Breathlessness even at maximal oxygen supplementation | All of the above | All of the above |
| Investigations as per patients profile | Ventilator support | |
| Deterioration of comorbid condition | Monitoring of comorbidities | Optimization of treatment of comorbidities |
| Early identification of complications | Monitoring of complications | Treatment of complications |
Figure 2Treatment options during home quarentine